IRIS
ADINOLFI, Luigi Elio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.088
NA - Nord America 12.842
AS - Asia 9.557
SA - Sud America 1.600
Continente sconosciuto - Info sul continente non disponibili 617
AF - Africa 126
OC - Oceania 10
Totale 48.840
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 15.032
US - Stati Uniti d'America 12.615
SG - Singapore 3.571
IE - Irlanda 2.684
CN - Cina 2.013
HK - Hong Kong 1.548
UA - Ucraina 1.416
BR - Brasile 1.375
IT - Italia 1.245
GB - Regno Unito 1.137
VN - Vietnam 1.044
DE - Germania 960
SE - Svezia 435
FI - Finlandia 394
TR - Turchia 357
KR - Corea 284
FR - Francia 277
IN - India 235
GR - Grecia 232
JP - Giappone 170
CA - Canada 111
AR - Argentina 81
MX - Messico 60
NL - Olanda 59
BD - Bangladesh 57
ID - Indonesia 44
EC - Ecuador 39
IQ - Iraq 39
ZA - Sudafrica 36
AT - Austria 35
BE - Belgio 35
PL - Polonia 31
CO - Colombia 27
MA - Marocco 27
ES - Italia 24
RO - Romania 21
EU - Europa 20
CZ - Repubblica Ceca 19
IR - Iran 19
CL - Cile 18
PY - Paraguay 18
UZ - Uzbekistan 18
EG - Egitto 17
PK - Pakistan 17
SA - Arabia Saudita 14
VE - Venezuela 14
MY - Malesia 13
IL - Israele 12
UY - Uruguay 12
HN - Honduras 10
PE - Perù 10
PH - Filippine 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
NP - Nepal 9
CR - Costa Rica 8
DZ - Algeria 8
KE - Kenya 8
LT - Lituania 8
BG - Bulgaria 7
JM - Giamaica 7
ET - Etiopia 6
KZ - Kazakistan 6
LB - Libano 6
OM - Oman 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
GE - Georgia 5
PA - Panama 5
PS - Palestinian Territory 5
PT - Portogallo 5
SC - Seychelles 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
JO - Giordania 4
SN - Senegal 4
AM - Armenia 3
CY - Cipro 3
HR - Croazia 3
KG - Kirghizistan 3
NO - Norvegia 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GT - Guatemala 2
LI - Liechtenstein 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 48.218
Salva come PNG Salva come JPEG
Città #
Moscow 5.246
Dublin 2.678
Jacksonville 2.128
Santa Clara 1.762
Hong Kong 1.527
Singapore 1.356
Chandler 1.305
San Jose 1.153
Ashburn 648
Princeton 417
Ho Chi Minh City 322
Roxbury 311
Bremen 297
Seoul 272
New York 263
Hanoi 261
Medford 253
Beijing 230
Ann Arbor 218
Boardman 215
Wilmington 195
Hefei 189
The Dalles 186
Woodbridge 186
Cambridge 182
Dallas 151
Bengaluru 128
San Mateo 124
Nanjing 108
Düsseldorf 102
São Paulo 102
Munich 95
Naples 95
Caserta 94
Los Angeles 92
Des Moines 87
Da Nang 78
Jinan 74
Mountain View 73
Napoli 65
Shenyang 57
Orem 54
Haiphong 49
Memphis 47
Milan 45
Norwalk 41
Nanchang 40
Helsinki 39
Tianjin 38
Rio de Janeiro 36
Shanghai 35
Zhengzhou 35
Guangzhou 34
Brussels 33
Venice 33
Amsterdam 32
Changsha 31
Frankfurt am Main 31
Atlanta 30
Nuremberg 30
Council Bluffs 28
Toronto 28
Belo Horizonte 27
Brasília 27
Washington 27
Chennai 26
Hangzhou 26
Houston 26
Chicago 25
Turku 25
Tokyo 24
Haikou 23
Warsaw 22
Campinas 21
Hải Dương 21
Kunming 20
Rome 20
Thái Nguyên 20
Montreal 19
Ningbo 19
Auburn Hills 18
Hebei 18
London 18
Bologna 17
Brooklyn 17
Curitiba 17
Salvador 17
Taizhou 17
Marano Di Napoli 16
Phoenix 16
Porto Alegre 16
Baghdad 15
Falkenstein 15
Johannesburg 15
Lanzhou 15
Tashkent 15
Biên Hòa 14
Hillsboro 14
Palermo 14
Can Tho 13
Totale 24.829
Salva come PNG Salva come JPEG
Nome #
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 223
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 209
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis 209
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 206
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 202
Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis 197
A genic and epigenetic combination therapy for liver cancer 194
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 193
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 191
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study 189
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 185
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 184
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 183
Sviluppo di un questionario autocompilato per la valutazione delle opinioni dei familiari sulle cause e le conseguenze psicosociali della schizofrenia (QOF) 179
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 178
Endocardite da Gemella morbillorum: descrizione di due casi 177
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 173
Activity of aminoglycosides against phagocytosed bacteria 171
Acute rhabdomiolisys in healthy woman. 171
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 170
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 167
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 166
Antimicrobici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici beta-lattamici 166
Chronic HCV infection and neurological and psychiatric disorders: an overview. 165
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 165
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 164
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 164
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 163
Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department 162
Sonoporation by microbubbles as gene therapy approach against liver cancer 161
Crioglobulinemia mista essenziale associata a cirrosi epatica: aspetti clinici e terapeutici.Esperienza su una casistica clinica 160
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 160
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 160
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 159
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 158
Predictors of early and late hepatocellular carcinoma recurrence 156
An in-vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC). 156
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 156
Circulating miRNA-195-5p and -451a in Patients with Acute Hemorrhagic Stroke in Emergency Department 155
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 153
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 153
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 153
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 153
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 152
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 152
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 152
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 152
[Enterococcal endocarditis: clinical and microbiological features of our series] 151
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 150
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 150
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 150
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 149
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 149
[Effect of levamisole on changes in the of hepatic RES induced by chronic ethanol poisoning] 146
Antibiotici 143
Chronic Hepatitis C Virus Infection and Depression. 143
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 142
Antimicrobials and biological activities of immune system 142
Antimicrobials and biological activities of immune system. Relazione al " Bologna,pag. 3-10. 141
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 140
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 140
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 140
Virological patterns of HCV patients with failure to interferon-free regimens. 137
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 136
Severe Hyponatremia in the elderly: the seasonalvariability in the emergency department 136
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 135
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci 135
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 135
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 135
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 134
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 133
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 133
antibiotici 133
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 133
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 131
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 131
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 131
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 130
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 129
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 129
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 129
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 129
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 128
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 128
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 127
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 127
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 127
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 127
HCV-related steatosis and risk of atherosclerosis 127
effetto di concentrazioni subinibenti ed effetto intrafagocitico di aztreonam, cefamandolo e netilmicina 127
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 127
Totale 15.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.428 0 9 32 60 879 22 29 67 110 220 212 788
2022/20235.182 462 88 63 392 679 405 17 334 2.492 43 103 104
2023/20241.971 149 69 76 174 718 241 23 63 8 22 131 297
2024/20256.167 26 76 86 130 989 944 801 498 787 1.031 466 333
2025/202624.112 758 862 1.128 1.231 1.956 13.998 1.397 749 983 507 369 174
2026/2027596 149 447 0 0 0 0 0 0 0 0 0 0
Totale 48.840